These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38499455)

  • 21. Spinal antinociceptive effects of the novel NOP receptor agonist PWT2-nociceptin/orphanin FQ in mice and monkeys.
    Rizzi A; Sukhtankar DD; Ding H; Hayashida K; Ruzza C; Guerrini R; Calò G; Ko MC
    Br J Pharmacol; 2015 Jul; 172(14):3661-70. PubMed ID: 25828800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endogenous nociceptin / orphanin FQ system involvement in hypothalamic-pituitary-adrenal axis responses: relevance to models of inflammation.
    Leggett JD; Dawe KL; Jessop DS; Fulford AJ
    J Neuroendocrinol; 2009 Nov; 21(11):888-97. PubMed ID: 19732291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo pharmacological characterization of the nociceptin/orphanin FQ receptor ligand Ac-RYYRIK-ol.
    Gündüz O; Rizzi A; Baldisserotto A; Guerrini R; Spagnolo B; Gavioli EC; Kocsis L; Magyar A; Benyhe S; Borsodi A; Calò G
    Eur J Pharmacol; 2006 Jun; 539(1-2):39-48. PubMed ID: 16682024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of the neuropeptide nociceptin/orphanin FQ in kainate seizures.
    Bregola G; Zucchini S; Rodi D; Binaschi A; D'Addario C; Landuzzi D; Reinscheid R; Candeletti S; Romualdi P; Simonato M
    J Neurosci; 2002 Nov; 22(22):10030-8. PubMed ID: 12427860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Site-specific estrogen and progestin regulation of orphanin FQ/nociceptin and nociceptin opioid receptor mRNA expression in the female rat limbic hypothalamic system.
    Sinchak K; Romeo HE; Micevych PE
    J Comp Neurol; 2006 May; 496(2):252-68. PubMed ID: 16538678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of the novel radioligand [(3)H]UFP-101 to recombinant human and native rat nociceptin/orphanin FQ receptors.
    Ibba M; Kitayama M; McDonald J; Calo G; Guerrini R; Farkas J; Toth G; Lambert DG
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Dec; 378(6):553-61. PubMed ID: 18807245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt
    Cerlesi MC; Ding H; Bird MF; Kiguchi N; Ferrari F; Malfacini D; Rizzi A; Ruzza C; Lambert DG; Ko MC; Calo G; Guerrini R
    Eur J Pharmacol; 2017 Jan; 794():115-126. PubMed ID: 27871910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endogenous orphanin FQ/nociceptin is involved in the development of morphine tolerance.
    Chung S; Pohl S; Zeng J; Civelli O; Reinscheid RK
    J Pharmacol Exp Ther; 2006 Jul; 318(1):262-7. PubMed ID: 16595734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ: behavioral and electrophysiological studies in mice.
    Nazzaro C; Rizzi A; Salvadori S; Guerrini R; Regoli D; Zeilhofer HU; Calo G
    Peptides; 2007 Mar; 28(3):663-9. PubMed ID: 17161885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supraspinal actions of nociceptin/orphanin FQ, morphine and substance P in regulating pain and itch in non-human primates.
    Ding H; Hayashida K; Suto T; Sukhtankar DD; Kimura M; Mendenhall V; Ko MC
    Br J Pharmacol; 2015 Jul; 172(13):3302-12. PubMed ID: 25752320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterisation of the Novel Mixed Mu-NOP Peptide Ligand Dermorphin-N/OFQ (DeNo).
    Bird MF; Cerlesi MC; Brown M; Malfacini D; Vezzi V; Molinari P; Micheli L; Di Cesare Mannelli L; Ghelardini C; Guerrini R; Calò G; Lambert DG
    PLoS One; 2016; 11(6):e0156897. PubMed ID: 27272042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ro 64-6198 [(1S,3aS)-8-(2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one] acts differently from nociceptin/orphanin FQ in rat periaqueductal gray slices.
    Chiou LC; Chuang KC; Wichmann J; Adam G
    J Pharmacol Exp Ther; 2004 Nov; 311(2):645-51. PubMed ID: 15254141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative biochemical and pharmacological characterization of a novel, NOP receptor selective hexapeptide, Ac-RYYRIR-ol.
    Bojnik E; Babos F; Fischetti C; Magyar A; Camarda V; Borsodi A; Bajusz S; Calo' G; Benyhe S
    Brain Res Bull; 2010 Mar; 81(4-5):477-83. PubMed ID: 19800951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-lasting antinociceptive spinal effects in primates of the novel nociceptin/orphanin FQ receptor agonist UFP-112.
    Hu E; Calò G; Guerrini R; Ko MC
    Pain; 2010 Jan; 148(1):107-113. PubMed ID: 19945794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of nociceptin/orphanin FQ-NOP receptor system inhibits tyrosine hydroxylase phosphorylation, dopamine synthesis, and dopamine D(1) receptor signaling in rat nucleus accumbens and dorsal striatum.
    Olianas MC; Dedoni S; Boi M; Onali P
    J Neurochem; 2008 Oct; 107(2):544-56. PubMed ID: 18717817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of nociceptin peptide (N/OFQ)-receptor (NOP) system activation in the airways.
    Singh SR; Sullo N; D'Agostino B; Brightling CE; Lambert DG
    Peptides; 2013 Jan; 39():36-46. PubMed ID: 23123316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor.
    Rizzi A; Spagnolo B; Wainford RD; Fischetti C; Guerrini R; Marzola G; Baldisserotto A; Salvadori S; Regoli D; Kapusta DR; Calo G
    Peptides; 2007 Jun; 28(6):1240-51. PubMed ID: 17532097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pro-nociceptin/orphanin FQ and NOP receptor mRNA levels in the forebrain of food deprived rats.
    Rodi D; Polidori C; Bregola G; Zucchini S; Simonato M; Massi M
    Brain Res; 2002 Dec; 957(2):354-61. PubMed ID: 12445978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of nociceptin/orphanin FQ and NOP receptors in the response to acute and repeated restraint stress in rats.
    Delaney G; Dawe KL; Hogan R; Hunjan T; Roper J; Hazell G; Lolait SJ; Fulford AJ
    J Neuroendocrinol; 2012 Dec; 24(12):1527-41. PubMed ID: 22835008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative study of [(pF)Phe4,Arg14,Lys15]nociceptin/orphanin FQ-NH2 (UFP-102) at NOP receptors in rat periaqueductal gray slices.
    Kuo CJ; Liao YY; Guerrini R; Calo' G; Chiou LC
    Eur J Pharmacol; 2008 Jan; 579(1-3):110-5. PubMed ID: 17976580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.